WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Cmap Week 3, RAAS inhibited by BNP & ANP, Congestive Heart Failure Causes Alcohol, Class III CHF Current medications Green = Continue Red = Discontinue Synthroid, Low heart pumping ability Patient EF value of 25% Class III CHF, ACEi ARBs Aldosterone Antagonist ADH Antagonist Can improve Negative remodeling, worsened LV Function, Pharmacological treatment pharmacological treatment Vascular Smooth Muscle, decreasing available Cl binding sites resulting in less water reabsorption, Right Sided Failure ???? Nocturia, K Sparing are competitive antagonist, inhibition of sodium and water reuptake causing decrease in blood volume, Congestive Heart Failure Causes Neuromuscular disease, Direct Renin Inhibitor Blocks Renin secretion from the kidnes, Diuretics ???? Thiazide, RAAS associated with Vasoconstriction causing an increase in afterload Hemodynamic alterations causing an increase in preload, Vasopressin Antagonist Drugs block Vasopressin, Vasopressin causing Vasodialation, Calcium Channel Blockers inhibits Reuptake of Calcium, Class III CHF Current medications Green = Continue Red = Discontinue Diltiazem, Congestive Heart Failure Causes Tachycardia, competitive antagonist competes with aldosterone for intracellular cytoplasmic receptors